ATE535232T1 - Retardierte freisetzung liposomaler anesthetischer zusammensetzungen - Google Patents

Retardierte freisetzung liposomaler anesthetischer zusammensetzungen

Info

Publication number
ATE535232T1
ATE535232T1 AT10003091T AT10003091T ATE535232T1 AT E535232 T1 ATE535232 T1 AT E535232T1 AT 10003091 T AT10003091 T AT 10003091T AT 10003091 T AT10003091 T AT 10003091T AT E535232 T1 ATE535232 T1 AT E535232T1
Authority
AT
Austria
Prior art keywords
anesthetic
local
encapsulated
liposomal
injection
Prior art date
Application number
AT10003091T
Other languages
English (en)
Inventor
Sinil Kim
Taehee Kim
Sharad Murdandi
Original Assignee
Pacira Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pacira Pharmaceuticals Inc filed Critical Pacira Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE535232T1 publication Critical patent/ATE535232T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT10003091T 1997-09-18 1998-09-18 Retardierte freisetzung liposomaler anesthetischer zusammensetzungen ATE535232T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5923397P 1997-09-18 1997-09-18

Publications (1)

Publication Number Publication Date
ATE535232T1 true ATE535232T1 (de) 2011-12-15

Family

ID=22021653

Family Applications (2)

Application Number Title Priority Date Filing Date
AT10003091T ATE535232T1 (de) 1997-09-18 1998-09-18 Retardierte freisetzung liposomaler anesthetischer zusammensetzungen
AT98948352T ATE463238T1 (de) 1997-09-18 1998-09-18 Retardierte freisetzung liposmaler anesthetischer zusammensetzungen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT98948352T ATE463238T1 (de) 1997-09-18 1998-09-18 Retardierte freisetzung liposmaler anesthetischer zusammensetzungen.

Country Status (16)

Country Link
US (5) US6045824A (de)
EP (3) EP2308470A1 (de)
JP (1) JP4467789B2 (de)
AT (2) ATE535232T1 (de)
AU (1) AU735588B2 (de)
CA (1) CA2304096C (de)
CY (1) CY1110135T1 (de)
DE (1) DE69841598D1 (de)
DK (1) DK1014946T3 (de)
ES (2) ES2343767T3 (de)
HK (1) HK1145966A1 (de)
IL (1) IL135060A (de)
NO (1) NO329727B1 (de)
NZ (1) NZ503513A (de)
PT (1) PT1014946E (de)
WO (1) WO1999013865A1 (de)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE535232T1 (de) * 1997-09-18 2011-12-15 Pacira Pharmaceuticals Inc Retardierte freisetzung liposomaler anesthetischer zusammensetzungen
US20020039596A1 (en) * 1997-11-14 2002-04-04 Hartoun Hartounian Production of multivesicular liposomes
CA2375371A1 (en) * 1999-06-04 2000-12-14 Skyepharma Inc. Oil-core compositions for the sustained release of hydrophobic drugs
US6566575B1 (en) 2000-02-15 2003-05-20 3M Innovative Properties Company Patterned absorbent article for wound dressing
US6977323B1 (en) 2000-02-17 2005-12-20 3M Innovative Properties Company Foam-on-film medical articles
US6716186B1 (en) 2000-08-16 2004-04-06 3M Innovative Properties Company Curable adhesive splints and methods
US6903243B1 (en) 2000-09-08 2005-06-07 3M Innovative Properties Company Multi-layer absorbent wound dressing
CA2447990C (en) * 2001-05-31 2012-01-31 Skyepharma Inc. Encapsulation of nanosuspensions in liposomes and microspheres
US7476400B2 (en) * 2001-11-13 2009-01-13 Ferndale Ip, Inc. High-concentration lidocaine compositions and methods for their preparation
US7005143B2 (en) 2002-04-12 2006-02-28 3M Innovative Properties Company Gel materials, medical articles, and methods
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US7612248B2 (en) 2002-12-19 2009-11-03 3M Innovative Properties Company Absorbent medical articles
US20050070688A1 (en) 2003-09-26 2005-03-31 3M Innovative Properties Company Reactive hydrophilic oligomers
US7384984B2 (en) 2003-12-10 2008-06-10 3M Innovative Properties Company Reactive hydrophilic oligomers
US7074839B2 (en) 2004-03-01 2006-07-11 3M Innovative Properties Company Crosslinkable hydrophilic materials from reactive oligomers having pendent photoinitiator groups
US7342047B2 (en) 2004-03-02 2008-03-11 3M Innovative Properties Company Crosslinkable hydrophilic materials from reactive oligomers having pendent unsaturated groups
WO2005097069A1 (en) * 2004-03-26 2005-10-20 Stiefel Laboratories, Inc. Topical skin protectant cosmetic compositions
US8609131B2 (en) 2005-01-25 2013-12-17 3M Innovative Properties Company Absorbent dressing comprising hydrophilic polymer prepared via Michael reaction
US7335690B2 (en) 2005-01-25 2008-02-26 3M Innovative Properties Company Crosslinkable hydrophilic materials from polymers having pendent Michael donor groups
AU2007240317B2 (en) 2006-04-20 2012-11-29 Amgen Inc. Stable emulsion formulations
US7981949B2 (en) 2006-05-23 2011-07-19 3M Innovative Properties Company Curable hydrophilic compositions
US8865208B2 (en) * 2007-05-29 2014-10-21 Pola Chemical Industries Inc. Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle
EP2344132A2 (de) * 2008-10-07 2011-07-20 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Liposomale systeme mit sphingomyelin
US20100305500A1 (en) * 2009-05-29 2010-12-02 Pacira Pharmaceuticals, Inc. Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent
CN102933200B (zh) 2009-12-18 2015-11-25 莱迪杜德制药公司 包含磷脂的单相凝胶组合物
US20110250264A1 (en) 2010-04-09 2011-10-13 Pacira Pharmaceuticals, Inc. Method for formulating large diameter synthetic membrane vesicles
WO2012058483A1 (en) 2010-10-28 2012-05-03 Pacira Pharmaceuticals, Inc. A sustained release formulation of a non-steroidal anti-inflammatory drug
GB201020860D0 (en) * 2010-12-09 2011-01-26 Univ Wolverhampton Disulfiram formulation and uses thereof
IN2014MN02214A (de) 2012-05-10 2015-07-17 Painreform Ltd
WO2014046191A1 (ja) * 2012-09-21 2014-03-27 テルモ株式会社 局所麻酔薬持続徐放性リポソーム製剤
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
AU2014223993B2 (en) 2013-02-28 2016-09-08 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid formulations and its compostions
US20140271923A1 (en) 2013-03-14 2014-09-18 Christopher Brian Reid Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
EP3134070B1 (de) 2014-04-21 2020-09-23 Heron Therapeutics, Inc. Zusammensetzungen aus einem polyorthoester und einem organischen sauren trägerstoff
WO2018048460A1 (en) 2014-04-21 2018-03-15 Heron Therapeutics, Inc. A pharmaceutical composition comprising a delivery system, an amide-type local anesthetic, and meloxicam
US9801945B2 (en) 2014-04-21 2017-10-31 Heron Therapeutics, Inc. Long-acting polymeric delivery systems
DK3134068T3 (da) 2014-04-21 2021-10-04 Heron Therapeutics Inc Langtidsvirkende polymerafgivelsessystemer
ES2905771T3 (es) * 2015-01-06 2022-04-12 Cellix Bio Private Ltd Composiciones y procedimientos para el tratamiento de la inflamación y del dolor
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
DK3291797T3 (da) 2015-05-04 2020-09-21 Versantis AG Metode til forberedelse af transmembran ph-gradiente vesikler
EP3317448B1 (de) 2015-06-30 2021-09-08 Tela Bio, Inc. Ecke-steppstich muster
EP3324882B1 (de) 2015-07-21 2023-10-25 Tela Bio, Inc. Nachgiebigkeitskontrolle von nähten in trägermaterialien
CN105708820B (zh) * 2016-03-25 2019-05-24 广州玻思韬控释药业有限公司 一种局麻剂的脂质体-聚合物微粒制剂及其制备方法
WO2017189772A1 (en) 2016-04-26 2017-11-02 Tela Bio, Inc. Hernia repair grafts having anti-adhesion barriers
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
WO2018094253A1 (en) 2016-11-18 2018-05-24 Pacira Pharmaceuticals, Inc. Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same
IL290150B2 (en) * 2016-12-26 2024-03-01 Cellix Bio Private Ltd Compounds and methods for treating chronic pain
BR112019018105A2 (pt) 2017-03-06 2020-03-24 Maruishi Pharmaceutical Co., Ltd. Composição de emulsão ácida
CN110869000A (zh) * 2017-05-11 2020-03-06 斯泰迪麦德有限公司 增强溶解度的含药制剂
US11793799B2 (en) * 2017-08-28 2023-10-24 Tlc Biopharmaceuticals Inc. Sustained-release anesthetic compositions and methods of preparation thereof
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
WO2019071246A2 (en) 2017-10-06 2019-04-11 Foundry Therapeutics, Inc. IMPLANTABLE DEPOSITS FOR CONTROLLED RELEASE OF ANALGESICS TO TREAT POSTOPERATIVE PAIN, AND DEVICES, SYSTEMS, AND RELATED METHODS
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
CN108078929B (zh) * 2017-12-28 2021-01-01 广州玻思韬控释药业有限公司 一种布比卡因多囊脂质体的制备方法以及布比卡因多囊脂质体制剂
CN108158998B (zh) * 2017-12-28 2021-01-26 广州玻思韬控释药业有限公司 一种布比卡因多囊脂质体制备装置
US11590262B2 (en) 2018-03-09 2023-02-28 Tela Bio, Inc. Surgical repair graft
EP3773504A1 (de) 2018-03-30 2021-02-17 TLC Biopharmaceuticals, Inc. Anästhetische zusammensetzungen mit verzögerter freisetzung und verfahren zur herstellung davon
CN108354903A (zh) * 2018-04-11 2018-08-03 西安力邦生物医药技术有限公司 一种局部麻醉镇痛缓释递药***及其制备方法和应用
EP3934575A4 (de) 2019-03-08 2022-12-28 Tela Bio, Inc. Texturierte medizinische textilien
CN113116823B (zh) * 2019-12-30 2024-02-20 江苏恒瑞医药股份有限公司 一种脂质体及其制备方法
EP4087540A4 (de) * 2020-01-06 2024-01-10 Pacira Pharmaceuticals, Inc. Behandlung von schmerzen in verbindung mit einem kaiserschnitt mit zusammensetzung aus liposomalen anästhetika mit verzögerter freisetzung
EP4087554A4 (de) 2020-01-10 2024-01-17 Pacira Pharmaceuticals, Inc. Behandlung von schmerzen durch subarachnoidale verabreichung von liposomalen anästhetischen zusammensetzungen mit verzögerter freisetzung
WO2021141959A1 (en) * 2020-01-10 2021-07-15 Pacira Pharmaceuticals, Inc. Treatment of pain by administration of sustained-release liposomal anesthetic compositions
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
WO2022150708A1 (en) * 2021-01-11 2022-07-14 Pacira Pharmaceuticals, Inc. Treatment of hip pain with sustained-release liposomal anesthetic compositions
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
WO2022159564A1 (en) * 2021-01-22 2022-07-28 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11931459B2 (en) 2021-03-19 2024-03-19 Pacira Pharmaceuticals, Inc. Treatment of pain in pediatric patients by administration of sustained-release liposomal anesthetic compositions
US20230137783A1 (en) * 2021-10-14 2023-05-04 Pacira Pharmaceuticals, Inc. Multivesicular liposome formulations of dexamethasone
WO2023064464A1 (en) * 2021-10-14 2023-04-20 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
WO2023164431A1 (en) * 2022-02-24 2023-08-31 Pacira Pharmaceuticals, Inc. Uses of bupivacaine multivesicular liposomes as stellate ganglion block
US11918565B1 (en) 2022-11-03 2024-03-05 Pacira Pharmaceuticals, Inc. Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions
WO2024102696A1 (en) * 2022-11-10 2024-05-16 Pacira Pharmaceuticals, Inc. Uses of bupivacaine multivesicular liposomes as stellate ganglion block for treating anxiety disorders and traumatic brain injury

Family Cites Families (140)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3684251A (en) 1970-09-08 1972-08-15 Us Army Apparatus for continuous emulsification
US3946994A (en) 1974-04-10 1976-03-30 Petrolite Corporation System for producing emulsions
IT1015665B (it) 1974-07-04 1977-05-20 Snam Progetti Metodo per la preparazione in con tinuo di emulsioni acqua olio ed apparecchiatura adatta allo scopo
CH588887A5 (de) 1974-07-19 1977-06-15 Battelle Memorial Institute
US4113765A (en) 1975-03-21 1978-09-12 Standard Oil Company (Indiana) Continuous process for sulfonating alkyl aromatics
US4897308A (en) 1975-06-30 1990-01-30 L'oreal Compositions comprising aqueous dispersions of lipid spheres
US4078052A (en) 1976-06-30 1978-03-07 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Large unilamellar vesicles (LUV) and method of preparing same
US4086257A (en) 1976-10-12 1978-04-25 Sears Barry D Phosphatidyl quaternary ammonium compounds
CH624011A5 (de) 1977-08-05 1981-07-15 Battelle Memorial Institute
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4310506A (en) 1979-02-22 1982-01-12 California Institute Of Technology Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species
DE2909906A1 (de) 1979-03-14 1980-10-02 Bayer Ag Verfahren zur kontinuierlichen herstellung von mikrokapseln
US4235587A (en) 1979-04-09 1980-11-25 Honeywell Inc. Flame responsive control circuit
JPS55153713A (en) 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
JPS6127918Y2 (de) 1979-11-07 1986-08-19
US4394372A (en) 1980-12-22 1983-07-19 The Procter & Gamble Company Process for making lipid membrane structures
US4454083A (en) 1981-12-21 1984-06-12 Appleton Papers Inc. Continuous microencapsulation
US4522803A (en) 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US5387410A (en) 1983-03-18 1995-02-07 Mallinckrodt, Inc. Method for enhancing magnetic resonance with compositions containing paramagnetic elements carried by liposomes
US4588578A (en) 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
US5169637A (en) 1983-03-24 1992-12-08 The Liposome Company, Inc. Stable plurilamellar vesicles
US5186941A (en) 1983-05-06 1993-02-16 Vestar, Inc. Vesicle formulation for the controlled release of therapeutic agents
JPH0768117B2 (ja) 1983-05-06 1995-07-26 ベスター・インコーポレイテツド 薬剤放出調整用小胞製剤
FR2548043A1 (fr) 1983-06-14 1985-01-04 Saint Gobain Vitrage Procede et dispositif pour la fabrication par coulee d'une couche optiquement homogene transparente a partir d'un melange de composants
US4725442A (en) 1983-06-17 1988-02-16 Haynes Duncan H Microdroplets of water-insoluble drugs and injectable formulations containing same
US4622219A (en) 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
US4478824A (en) 1983-08-08 1984-10-23 Franco Robert S Method for altering red blood cell function and survival
JPS60100516A (ja) 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4599227A (en) 1983-11-07 1986-07-08 Wisconsin Alumni Research Foundation Injectable pharmaceutical preparation for the induction of multiple follicular growth
WO1995013796A1 (en) * 1993-11-16 1995-05-26 Depotech Corporation Vesicles with controlled release of actives
US4599342A (en) 1984-01-16 1986-07-08 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US4744989A (en) 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
US5141674A (en) 1984-03-08 1992-08-25 Phares Pharmaceutical Research N.V. Methods of preparing pro-liposome dispersions and aerosols
JPH0753661B2 (ja) 1984-03-08 1995-06-07 フアレス フアーマスーチカル リサーチ エヌブイ プロ―リポソーム組成物及びリポソームの水性分散物を作る方法
US4610868A (en) 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
DE3421865A1 (de) 1984-06-13 1985-12-19 Bayer Ag, 5090 Leverkusen Kontinuierliche herstellung von mikrokapseldispersionen
US5077056A (en) 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US4761288A (en) 1984-09-24 1988-08-02 Mezei Associates Limited Multiphase liposomal drug delivery system
IE58981B1 (en) 1985-10-15 1993-12-15 Vestar Inc Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
EP0225130B1 (de) 1985-11-22 1991-10-30 Takeda Chemical Industries, Ltd. Liposomzusammensetzung
US5244678A (en) * 1986-01-14 1993-09-14 Ire-Celltarg S.A. Pharmaceutical composition containing a local anesthetic and/or centrally acting analgesic encapsulated in liposomes
JPH0751496B2 (ja) 1986-04-02 1995-06-05 武田薬品工業株式会社 リポソ−ムの製造法
US4861597A (en) 1986-05-20 1989-08-29 Wako Pure Chemical Industries, Ltd. Novel functionallized liposomes and a process for production thereof
US5204112A (en) 1986-06-16 1993-04-20 The Liposome Company, Inc. Induction of asymmetry in vesicles
US5147134A (en) 1986-08-21 1992-09-15 Petrolite Corporation Process for the continuous production of high-internal-phase-ratio emulsions
US4877619A (en) 1986-08-25 1989-10-31 Vestar, Inc. Liposomal vesicles for intraperitoneal administration of therapeutic agents
US4776991A (en) 1986-08-29 1988-10-11 The United States Of America As Represented By The Secretary Of The Navy Scaled-up production of liposome-encapsulated hemoglobin
US4752425A (en) 1986-09-18 1988-06-21 Liposome Technology, Inc. High-encapsulation liposome processing method
US4781871A (en) 1986-09-18 1988-11-01 Liposome Technology, Inc. High-concentration liposome processing method
US4844620A (en) 1986-11-24 1989-07-04 Petrolite Corporation System for producing high-internal-phase-ratio emulsion products on a continuous basis
US4920016A (en) 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
GB8704171D0 (en) 1987-02-23 1987-04-01 Clayton Found Res Multivesicular liposomes
US5723147A (en) 1987-02-23 1998-03-03 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
DK86988A (da) 1987-02-25 1988-08-26 Takeda Chemical Industries Ltd Liposompraeparat og anvendelse deraf
JP2666345B2 (ja) 1987-04-16 1997-10-22 武田薬品工業株式会社 リポソーム製剤およびその製造法
CA1337273C (en) 1987-07-29 1995-10-10 Robert P. Lenk Method for size separation of particles
JP2877160B2 (ja) 1987-07-29 1999-03-31 ザ リポソーム カンパニー，インコーポレイテッド 粒子のサイズによる分離方法
IE63518B1 (en) 1987-11-18 1995-05-03 Vestar Inc Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
US4946683A (en) 1987-11-18 1990-08-07 Vestar, Inc. Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
US4921644A (en) 1988-02-29 1990-05-01 Technology Unlimited, Inc. Mucin directed lipsome
EP0331504B1 (de) 1988-03-04 1992-06-10 Takeda Chemical Industries, Ltd. Liposom-Zusammensetzung
US5948441A (en) 1988-03-07 1999-09-07 The Liposome Company, Inc. Method for size separation of particles
US5261903A (en) 1988-04-11 1993-11-16 M.D. Inc. Composite anesthetic article and method of use
US5422120A (en) 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
US5576017A (en) 1988-05-30 1996-11-19 Depotech Corporation Heterovesicular liposomes
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products
IL91664A (en) 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
BE1001869A3 (fr) 1988-10-12 1990-04-03 Franz Legros Procede d'encapsulation liposomiale d'antibiotiques aminoglucosidiques, en particulier de la gentamycine.
US4921853A (en) 1988-11-14 1990-05-01 Michigan State University Method for producing analgesia in mammals
US4908463A (en) 1988-12-05 1990-03-13 Ethyl Corporation Aluminoxane process
US5049392A (en) * 1989-01-18 1991-09-17 The Liposome Company, Inc. Osmotically dependent vesicles
US5364632A (en) 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
US5227170A (en) 1989-06-22 1993-07-13 Vestar, Inc. Encapsulation process
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US5227165A (en) 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5334381A (en) 1989-12-22 1994-08-02 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
NZ237464A (en) 1990-03-21 1995-02-24 Depotech Corp Liposomes with at least two separate chambers encapsulating two separate biologically active substances
US5091187A (en) 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5246707A (en) 1990-04-26 1993-09-21 Haynes Duncan H Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
US5169934A (en) 1990-05-14 1992-12-08 Anergen, Inc. Intracellularly cleavable compounds
USRE35192E (en) 1990-11-13 1996-03-26 Phoenix Surgical Products, Inc. Post-surgical anesthesia at a continuous and progressively decreasing administration rate
IS1685B (is) 1990-12-11 1998-02-24 Bracco International B.V. Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum
SE506930C2 (sv) 1991-03-25 1998-03-02 Svedala Pumps & Process Ab Förfarande och anordning för förtjockning av finpartikulära suspensioner
US5885260A (en) 1991-05-30 1999-03-23 Mehl, Sr.; Thomas L. Freeze-dried liposome delivery system for application of skin treatment agents
ES2078034T3 (es) * 1991-07-03 1995-12-01 Vestar Inc Tecnica de carga para preparar liposomas que contienen farmacos.
US5977326A (en) 1991-08-06 1999-11-02 Salford Ultrafine Chemicals And Research Limited Process for making morphine-6-glucuronide or substituted morphine-6-glucuronide
SE9200952D0 (sv) 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
US5922340A (en) 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
DK0665743T3 (da) 1992-10-14 2002-04-08 Liposome Co Inc Interdigitationsfusions-liposomer og -geler
JPH08505312A (ja) 1992-10-16 1996-06-11 ザックセ，アンドレアス 液状分散系を製造する方法及び装置
US5321012A (en) 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
JPH06247842A (ja) 1993-02-23 1994-09-06 Green Cross Corp:The リポソーム組成物の製造方法
EP0616801B1 (de) 1993-03-24 1998-05-27 Novartis AG Verfahren zur Herstellung einer Liposomendispersion im Hochdruckbereich
WO1994022430A1 (en) 1993-04-02 1994-10-13 The Liposome Company, Inc. Method of producing liposomes
US5891842A (en) 1993-04-09 1999-04-06 Trustees Of Tufts College Methodology for eliciting an analgesic response in a living subject
ES2188612T3 (es) 1993-04-22 2003-07-01 Skyepharma Inc Liposomas multivesiculares de ciclodextrina para encapsular compuestos farmacologicos y metodos para su uso.
JPH09503743A (ja) 1993-05-14 1997-04-15 デポテック コーポレーション 神経学的疾患の治療方法
US5455044A (en) 1993-05-14 1995-10-03 Depotech Corporation Method for treating neurological disorders
AU6832794A (en) 1993-05-19 1994-12-12 Liposome Company, Inc., The Liposome having a multicomponent bilayer which contains a bioactive agent as an integral component of the bilayer
US5776486A (en) 1993-05-28 1998-07-07 Aphios Corporation Methods and apparatus for making liposomes containing hydrophobic drugs
US5554382A (en) 1993-05-28 1996-09-10 Aphios Corporation Methods and apparatus for making liposomes
US5425707A (en) * 1993-06-28 1995-06-20 Goldberg; Larry Method for non-surgical treatment of carpal tunnel syndrome
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
US5853755A (en) 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
GB9320668D0 (en) 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
WO1995010277A1 (en) 1993-10-13 1995-04-20 Chiroscience Limited Analgesic agent and its use
GB9321061D0 (en) 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
US5849763A (en) 1993-10-13 1998-12-15 Darwin Discovery Limited Use of levobupivacaine as an anesthetic agent
US5766627A (en) * 1993-11-16 1998-06-16 Depotech Multivescular liposomes with controlled release of encapsulated biologically active substances
US5451408A (en) 1994-03-23 1995-09-19 Liposome Pain Management, Ltd. Pain management with liposome-encapsulated analgesic drugs
SE518578C2 (sv) 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US5741516A (en) 1994-06-20 1998-04-21 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
US6048545A (en) * 1994-06-24 2000-04-11 Biozone Laboratories, Inc. Liposomal delivery by iontophoresis
US6066331A (en) 1994-07-08 2000-05-23 Barenholz; Yechezkel Method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers
SE9402453D0 (sv) 1994-07-12 1994-07-12 Astra Ab New pharmaceutical preparation
DE4430592A1 (de) 1994-08-20 1996-02-22 Max Delbrueck Centrum Liposomale Zubereitung, ihre Herstellung und ihre Verwendung
US5993850A (en) 1994-09-13 1999-11-30 Skyepharma Inc. Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
US5589189A (en) 1994-09-14 1996-12-31 Nexstar Pharmaceuticals, Inc. Liposome dispersion
US5702722A (en) 1994-09-30 1997-12-30 Bracco Research S.A. Liposomes with enhanced entrapment capacity, method and use
IL115849A0 (en) 1994-11-03 1996-01-31 Merz & Co Gmbh & Co Tangential filtration preparation of liposomal drugs and liposome product thereof
WO1996024330A1 (en) 1995-02-10 1996-08-15 Medtronic, Inc. Method and device for administering analgesics
US5931809A (en) * 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
US5942253A (en) 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
SE505146C2 (sv) * 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning
US6046187A (en) 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
US5997899A (en) 1996-10-01 1999-12-07 Skyepharma Inc. Method for producing liposomes with increased percent of compound encapsulated
SK283760B6 (sk) 1996-10-15 2004-01-08 The Liposome Company, Inc. Farmaceutický prostriedok na dopravu bioaktívnych látok
US5837282A (en) 1996-10-30 1998-11-17 University Of British Columbia Ionophore-mediated liposome loading
WO1998024415A1 (en) 1996-12-02 1998-06-11 The Regents Of The University Of California A bilayer structure which encapsulates multiple containment units and uses thereof
US5865184A (en) 1997-01-13 1999-02-02 Takiguchi; Tetsuo Combined spinal and epidural anesthesia
US5891467A (en) 1997-01-31 1999-04-06 Depotech Corporation Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
US5827533A (en) 1997-02-06 1998-10-27 Duke University Liposomes containing active agents aggregated with lipid surfactants
US5864184A (en) * 1997-03-05 1999-01-26 Brian Page Platner Interface circuitry for facilitating installation of a control device
PT1201241E (pt) 1997-03-13 2010-12-02 James N Campbell Composições contendo capsaicina ou análogos de capsaicina e um anestésico
US6306432B1 (en) 1997-09-08 2001-10-23 Chiron Corporation High and low load formulations of IGF-I in multivesicular liposomes
US6106858A (en) 1997-09-08 2000-08-22 Skyepharma, Inc. Modulation of drug loading in multivescular liposomes
ATE535232T1 (de) * 1997-09-18 2011-12-15 Pacira Pharmaceuticals Inc Retardierte freisetzung liposomaler anesthetischer zusammensetzungen
US5955476A (en) * 1997-11-18 1999-09-21 Celgene Corporation Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels

Also Published As

Publication number Publication date
US20060078606A1 (en) 2006-04-13
US9192575B2 (en) 2015-11-24
PT1014946E (pt) 2010-07-06
US20120231070A1 (en) 2012-09-13
NO20001410D0 (no) 2000-03-17
NZ503513A (en) 2004-12-24
JP4467789B2 (ja) 2010-05-26
IL135060A0 (en) 2001-05-20
DE69841598D1 (de) 2010-05-20
EP1014946B1 (de) 2010-04-07
JP2001516714A (ja) 2001-10-02
EP2308470A1 (de) 2011-04-13
US20130344132A1 (en) 2013-12-26
ATE463238T1 (de) 2010-04-15
AU9494298A (en) 1999-04-05
EP1014946A4 (de) 2006-05-17
US6045824A (en) 2000-04-04
IL135060A (en) 2005-12-18
NO329727B1 (no) 2010-11-30
US8182835B2 (en) 2012-05-22
CA2304096C (en) 2003-09-09
CY1110135T1 (el) 2015-01-14
DK1014946T3 (da) 2010-06-28
ES2343767T3 (es) 2010-08-09
CA2304096A1 (en) 1999-03-25
EP2198854A2 (de) 2010-06-23
NO20001410L (no) 2000-05-15
AU735588B2 (en) 2001-07-12
EP2198854A3 (de) 2011-01-05
US8834921B2 (en) 2014-09-16
WO1999013865A1 (en) 1999-03-25
HK1145966A1 (en) 2011-05-13
ES2373861T3 (es) 2012-02-09
EP1014946A1 (de) 2000-07-05
US9205052B2 (en) 2015-12-08
US20130189349A1 (en) 2013-07-25
EP2198854B1 (de) 2011-11-30

Similar Documents

Publication Publication Date Title
ATE535232T1 (de) Retardierte freisetzung liposomaler anesthetischer zusammensetzungen
NO20022014L (no) En fast oral kontrollert frigjorende doseringsform inneholdende hydrokodon
CA2503810A1 (en) Therapeutic agent for fibromyalgia
NO863620D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
HUP9700322A2 (hu) Hosszabb lokálanesztézist biztosító készítmény és módszerek
HK1031197A1 (en) Osmotic dosage form comprising first and second coats
BR0109150A (pt) Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente
EP0724885A4 (de) Pernasale zusammensetzung und diese enthaltende pernasale zubereitung
AU1046202A (en) Transdermal therapeutic system for treating restless-legs-syndrome
DK0754034T3 (da) Brusende farmaceutiske formuleringer indeholdende biologisk nedbrydelige mikrokapsler med kontrolleret afgivelse
PT904067E (pt) Dextrometorfan como agente antitussico administrado transdermicamente
CA2454699A1 (en) Method for treating primary insomnia
DK408188A (da) Injicerbart middel til kontrolleret frigivelse af opioid-analgetika
WO1998036778A8 (en) Sustained drug delivery and compositions useful therefor
UA38897A (uk) Спосіб профілактики дисемінації злоякісних пухлин при діагностичних та хірургічних втручаннях